1,781 Shares in The Clorox Company (NYSE:CLX) Acquired by GUNN & Co INVESTMENT MANAGEMENT INC.

GUNN & Co INVESTMENT MANAGEMENT INC. bought a new position in shares of The Clorox Company (NYSE:CLX) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 1,781 shares of the company’s stock, valued at approximately $254,000.

A number of other institutional investors also recently bought and sold shares of the company. Fortitude Family Office LLC acquired a new stake in Clorox in the 4th quarter valued at about $29,000. Tyler Stone Wealth Management increased its position in Clorox by 64.5% during the third quarter. Tyler Stone Wealth Management now owns 255 shares of the company’s stock worth $33,000 after buying an additional 100 shares in the last quarter. Hartford Financial Management Inc. raised its holdings in shares of Clorox by 57.1% in the fourth quarter. Hartford Financial Management Inc. now owns 256 shares of the company’s stock worth $37,000 after acquiring an additional 93 shares during the last quarter. Valley National Advisers Inc. lifted its position in shares of Clorox by 458.3% in the fourth quarter. Valley National Advisers Inc. now owns 268 shares of the company’s stock valued at $38,000 after acquiring an additional 220 shares in the last quarter. Finally, BKM Wealth Management LLC acquired a new stake in shares of Clorox during the fourth quarter valued at $41,000. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Stock Up 0.8 %

NYSE:CLX traded up $1.05 during trading hours on Monday, hitting $139.28. The stock had a trading volume of 1,234,761 shares, compared to its average volume of 1,273,466. The company has a market cap of $17.30 billion, a PE ratio of 71.62, a price-to-earnings-growth ratio of 2.13 and a beta of 0.44. The business has a 50 day simple moving average of $148.45 and a two-hundred day simple moving average of $143.43. The Clorox Company has a 1-year low of $114.68 and a 1-year high of $170.43. The company has a current ratio of 0.90, a quick ratio of 0.53 and a debt-to-equity ratio of 9.73.

Clorox (NYSE:CLX) last released its quarterly earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, beating analysts’ consensus estimates of $1.33 by $0.38. The business had revenue of $1.81 billion during the quarter, compared to analyst estimates of $1.87 billion. Clorox had a net margin of 3.33% and a return on equity of 302.49%. The business’s revenue was down 5.3% on a year-over-year basis. During the same period last year, the business earned $1.51 EPS. Analysts predict that The Clorox Company will post 5.83 EPS for the current year.

Clorox Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be issued a dividend of $1.20 per share. The ex-dividend date of this dividend is Tuesday, April 23rd. This represents a $4.80 annualized dividend and a yield of 3.45%. Clorox’s dividend payout ratio is presently 248.71%.

Analyst Upgrades and Downgrades

CLX has been the topic of a number of recent research reports. JPMorgan Chase & Co. reduced their target price on shares of Clorox from $159.00 to $158.00 and set a “neutral” rating on the stock in a report on Wednesday, May 1st. Citigroup lowered their price objective on Clorox from $155.00 to $150.00 and set a “neutral” rating for the company in a research report on Wednesday, May 1st. Evercore ISI dropped their price objective on shares of Clorox from $145.00 to $142.00 and set an “underperform” rating for the company in a research note on Wednesday, May 1st. Wells Fargo & Company decreased their target price on shares of Clorox from $140.00 to $135.00 and set an “underweight” rating on the stock in a research report on Thursday. Finally, UBS Group decreased their price target on shares of Clorox from $164.00 to $159.00 and set a “neutral” rating on the stock in a report on Wednesday, May 1st. Four equities research analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $146.43.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.